Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy

Immune checkpoint blockade therapy is a powerful treatment strategy for many cancer types. Many patients will have limited responses to monotherapy targeted to a single immune checkpoint. Both inhibitory and stimulatory immune checkpoints continue to be discovered. Additionally, many receptors previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahavi, David J., Weiner, Louis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337574/
https://www.ncbi.nlm.nih.gov/pubmed/30621125
http://dx.doi.org/10.3390/ijms20010158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337574/
https://www.ncbi.nlm.nih.gov/pubmed/30621125
http://dx.doi.org/10.3390/ijms20010158

Ejemplares similares